Crossmark

The plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancer

Crossref DOI link: https://doi.org/10.1186/s12885-018-4755-1

Published Online: 2018-09-03

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vanhove, K.

Giesen, P.

Owokotomo, O. E.

Mesotten, L.

Louis, E.

Shkedy, Z.

Thomeer, M.

Adriaensens, P.
License Information

Text and Data Mining valid from 2018-09-03
More Information

Article History

Received: 26 October 2017

Accepted: 16 August 2018

First Online: 3 September 2018

Ethics approval and consent to participate

: Institutional review board approval was waived by the responsible Ethics Committee of Ziekenhuis Oost-Limburg, Genk, given the retrospective study design and analysis of clinical data. Patient records and information were anonymized prior to analysis in all working stages. For this type of research, a formal consent in not required. As this study is based on the patient population of the NCT02024113-trial, formal consents are available.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.